The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even companies that have no revenue, no profit, and a record of falling short, can manage ...
Boston Scientific (BSX) closed the most recent trading day at $97.79, moving +2.42% from the previous trading session. This change outpaced the S&P 500's 0.62% gain on the day. On the other hand, the ...
MARLBOROUGH, Mass., Jan. 2, 2026 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will participate in the 44 th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13 th, 2026, in ...
MARLBOROUGH, Mass., Jan. 12, 2026 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced it has entered into a definitive agreement to acquire Valencia Technologies Corporation, a ...
WASHINGTON (dpa-AFX) - Boston Scientific Corp. (BSX), a medical devices manufacturer, Monday announced that it has agreed to acquire Valencia Technologies Corporation, a privately held medical ...
GlobalData on MSN
Boston Scientific buys Tivus system developer SoniVie in $540m deal
Boston Scientific is acquiring SoniVie, the developer of the catheter-based Tivus intravascular ultrasound system. With a ...
Boston Scientific’s BSX Cardiovascular segment operates in a $50 billion market, projected to grow nearly 9% over the 2026-2028 long-range plan (LRP). Management expects the business to outpace ...
Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results